TMAO activates the endoplasmic reticulum (ER) stress kinase PERK, triggers gasdermin E-mediated tumor cell pyroptosis, and boosts CD8 + T cell-mediated anti-tumor immunity in vivo in triple-negative breast cancer (Wang et al., 2022). This evidence concerns the gene CD8A and neoplasm.